The Steady-State Pharmacokinetics Of Rivoglitazone (Cs-011) Are Not Affected By Coadminstration Of The Potent Cyp3a4 Inhibitor Itraconazole.
CLINICAL PHARMACOLOGY & THERAPEUTICS（2007）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined